109 related articles for article (PubMed ID: 15602200)
1. Antibodies to type III group B streptococcal polysaccharide in breast milk.
Edwards MS; Munoz FM; Baker CJ
Pediatr Infect Dis J; 2004 Oct; 23(10):961-3. PubMed ID: 15602200
[TBL] [Abstract][Full Text] [Related]
2. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
3. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
[TBL] [Abstract][Full Text] [Related]
5. The potential impact of group B streptococcal antibodies in breast milk.
Weisman LE; Dobson FM
Adv Exp Med Biol; 1991; 310():345-51. PubMed ID: 1809009
[No Abstract] [Full Text] [Related]
6. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
7. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
Edwards MS; Fuselier PA; Rench MA; Kasper DL; Baker CJ
Infect Immun; 1984 May; 44(2):257-61. PubMed ID: 6370863
[TBL] [Abstract][Full Text] [Related]
8. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery.
Campbell JR; Hillier SL; Krohn MA; Ferrieri P; Zaleznik DF; Baker CJ
Obstet Gynecol; 2000 Oct; 96(4):498-503. PubMed ID: 11004347
[TBL] [Abstract][Full Text] [Related]
9. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
10. Breast milk antibody to the capsular polysaccharide of Haemophilus influenzae type b.
Pichichero ME; Sommerfelt AE; Steinhoff MC; Insel RA
J Infect Dis; 1980 Nov; 142(5):694-8. PubMed ID: 6970233
[TBL] [Abstract][Full Text] [Related]
11. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
[TBL] [Abstract][Full Text] [Related]
12. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults.
Baker CJ; Rench MA; Paoletti LC; Edwards MS
Vaccine; 2007 Jan; 25(1):55-63. PubMed ID: 16919857
[TBL] [Abstract][Full Text] [Related]
13. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
[TBL] [Abstract][Full Text] [Related]
14. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
[TBL] [Abstract][Full Text] [Related]
15. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase antigen density and avidity of antibodies detected in anti-group B streptococcal type III IgG enzyme immunoassays.
Feldman RG; Hamel ME; Breukels MA; Concepcion NF; Anthony BF
J Immunol Methods; 1994 Mar; 170(1):37-45. PubMed ID: 7512607
[TBL] [Abstract][Full Text] [Related]
17. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
